The following table provides an overview of the latest patents of Medivation Prostate Therapeutics Llc that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3725778Aug 18, 2021Formulations Of Enzalutamide11
EP2739153Aug 22, 2018Treatment Of Breast Cancer1